Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 167320 |
| Drug Identification Number | 02330547 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIP/TAZO |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 1.5G 12G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1PSOIJ |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-18 |
| Estimated end date | 2022-09-23 |
| Actual end date | 2022-09-21 |
| Shortage status | Resolved |
| Updated date | 2022-09-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-09-22 | English | Compare |
| v5 | 2022-09-21 | French | Compare |
| v4 | 2022-09-21 | English | Compare |
| v3 | 2022-08-18 | French | Compare |
| v2 | 2022-08-18 | English | Compare |
| v1 | 2022-08-18 | English | Compare |
Showing 1 to 6 of 6